Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia

被引:31
作者
Wandler, Anica M. [1 ]
Huang, Benjamin J. [1 ]
Craig, Jeffrey W. [2 ]
Hayes, Kathryn [1 ]
Yan, Hannah [1 ]
Meyer, Lauren K. [1 ]
Scacchetti, Alessandro [3 ]
Monsalve, Gabriela [3 ]
Dail, Monique [4 ]
Li, Qing [5 ]
Wong, Jasmine C. [1 ]
Weinberg, Olga [6 ]
Hasserjian, Robert P. [7 ]
Kogan, Scott C. [8 ]
Jonsson, Philip [9 ,10 ]
Yamamoto, Keith [3 ]
Sampath, Deepak [4 ]
Nakitandwe, Joy [11 ]
Downing, James R. [11 ]
Zhang, Jinghui [12 ]
Aster, Jon C. [2 ]
Taylor, Barry S. [9 ,10 ,13 ]
Shannon, Kevin [1 ]
机构
[1] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA
[2] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
[3] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA
[4] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA
[5] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[6] Boston Childrens Hosp, Dept Pathol, Boston, MA USA
[7] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[8] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA
[9] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[10] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA
[11] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA
[12] St Jude Childrens Res Hosp, Dept Computat Biol, 332 N Lauderdale St, Memphis, TN 38105 USA
[13] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA
基金
美国国家卫生研究院;
关键词
RELAPSED CHILDHOOD; INDUCED APOPTOSIS; GENOMIC ANALYSIS; PROGNOSTIC VALUE; MEK INHIBITION; MUTATIONS; CHILDREN; PATHWAY; GENE; EFFICACY;
D O I
10.1038/s41375-020-0748-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite decades of clinical use, mechanisms of glucocorticoid resistance are poorly understood. We treated primary murine T lineage acute lymphoblastic leukemias (T-ALLs) with the glucocorticoid dexamethasone (DEX) alone and in combination with the pan-PI3 kinase inhibitor GDC-0941 and observed a robust response to DEX that was modestly enhanced by GDC-0941. Continuous in vivo treatment invariably resulted in outgrowth of drug-resistant clones, similar to 30% of which showed markedly reduced glucocorticoid receptor (GR) protein expression. A similar proportion of relapsed human T-ALLs also exhibited low GR protein levels. De novo or preexisting mutations in the gene encoding GR (Nr3c1) occurred in relapsed clones derived from multiple independent parental leukemias. CRISPR/Cas9 gene editing confirmed that loss of GR expression confers DEX resistance. Exposing drug-sensitive T-ALLs to DEX in vivo altered transcript levels of multiple genes, and this response was attenuated in relapsed T-ALLs. These data implicate reduced GR protein expression as a frequent cause of glucocorticoid resistance in T-ALL.
引用
收藏
页码:2025 / 2037
页数:13
相关论文
共 61 条
[21]   Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling [J].
Jamieson, CAM ;
Yamamoto, KR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (13) :7319-7324
[22]   Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia [J].
Jing, Duohui ;
Huang, Yizhou ;
Liu, Xiaoyun ;
Sia, Keith C. S. ;
Zhang, Julia C. ;
Tai, Xiaolu ;
Wang, Meng ;
Toscan, Cara E. ;
McCalmont, Hannah ;
Evans, Kathryn ;
Mayoh, Chelsea ;
Poulos, Rebecca C. ;
Span, Miriam ;
Mi, Jianqing ;
Zhang, Chao ;
Wong, Jason W. H. ;
Beck, Dominik ;
Pimanda, John E. ;
Lock, Richard B. .
CANCER CELL, 2018, 34 (06) :906-+
[23]   An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia [J].
Knoechel, Birgit ;
Roderick, Justine E. ;
Williamson, Kaylyn E. ;
Zhu, Jiang ;
Lohr, Jens G. ;
Cotton, Matthew J. ;
Gillespie, Shawn M. ;
Fernandez, Daniel ;
Ku, Manching ;
Wang, Hongfang ;
Piccioni, Federica ;
Silver, Serena J. ;
Jain, Mohit ;
Pearson, Daniel ;
Kluk, Michael J. ;
Ott, Christopher J. ;
Shultz, Leonard D. ;
Brehm, Michael A. ;
Greiner, Dale L. ;
Gutierrez, Alejandro ;
Stegmaier, Kimberly ;
Kung, Andrew L. ;
Root, David E. ;
Bradner, James E. ;
Aster, Jon C. ;
Kelliher, Michelle A. ;
Bernstein, Bradley E. .
NATURE GENETICS, 2014, 46 (04) :364-+
[24]   Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation [J].
Kunz, Joachim B. ;
Rausch, Tobias ;
Bandapalli, Obul R. ;
Eilers, Juliane ;
Pechanska, Paulina ;
Schuessele, Stephanie ;
Assenov, Yassen ;
Stuetz, Adrian M. ;
Kirschner-Schwabe, Renate ;
Hof, Jana ;
Eckert, Cornelia ;
von Stackelberg, Arend ;
Schrappe, Martin ;
Stanulla, Martin ;
Koehler, Rolf ;
Avigad, Smadar ;
Elitzur, Sarah ;
Handgretinger, Rupert ;
Benes, Vladimir ;
Weischenfeldt, Joachim ;
Korbel, Jan O. ;
Muckenthaler, Martina U. ;
Kulozik, Andreas E. .
HAEMATOLOGICA, 2015, 100 (11) :1442-1450
[25]   ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling [J].
Kuster, Lilian ;
Grausenburger, Reinhard ;
Fuka, Gerhard ;
Kaindl, Ulrike ;
Krapf, Gerd ;
Inthal, Andrea ;
Mann, Georg ;
Kauer, Maximilian ;
Rainer, Johannes ;
Kofler, Reinhard ;
Hall, Andrew ;
Metzler, Markus ;
Meyer, Lueder Hinrich ;
Meyer, Claus ;
Harbott, Jochen ;
Marschalek, Rolf ;
Strehl, Sabine ;
Haas, Oskar A. ;
Panzer-Gruemayer, Renate .
BLOOD, 2011, 117 (09) :2658-2667
[26]   Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras [J].
Lauchle, Jennifer O. ;
Kim, Doris ;
Le, Doan T. ;
Akagi, Keiko ;
Crone, Michael ;
Krisman, Kimberly ;
Warner, Kegan ;
Bonifas, Jeannette M. ;
Li, Qing ;
Coakley, Kristen M. ;
Diaz-Flores, Ernesto ;
Gorman, Matthew ;
Przybranowski, Sally ;
Tran, Mary ;
Kogan, Scott C. ;
Roose, Jeroen P. ;
Copeland, Neal G. ;
Jenkins, Nancy A. ;
Parada, Luis ;
Wolff, Linda ;
Sebolt-Leopold, Judith ;
Shannon, Kevin .
NATURE, 2009, 461 (7262) :411-U110
[27]  
Lauten M, 2003, HAEMATOLOGICA, V88, P1253
[28]   Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia [J].
Li, Benshang ;
Brady, Samuel W. ;
Ma, Xiaotu ;
Shen, Shuhong ;
Zhang, Yingchi ;
Li, Yongjin ;
Szlachta, Karol ;
Dong, Li ;
Liu, Yu ;
Yang, Fan ;
Wang, Ningling ;
Flasch, Diane A. ;
Myers, Matthew A. ;
Mulder, Heather L. ;
Ding, Lixia ;
Liu, Yanling ;
Tian, Liqing ;
Hagiwara, Kohei ;
Xu, Ke ;
Zhou, Xin ;
Sioson, Edgar ;
Wang, Tianyi ;
Yang, Liu ;
Zhao, Jie ;
Zhang, Hui ;
Shao, Ying ;
Sun, Hongye ;
Sun, Lele ;
Cai, Jiaoyang ;
Sun, Hui-Ying ;
Lin, Ting-Nien ;
Du, Lijuan ;
Li, Hui ;
Rusch, Michael ;
Edmonson, Michael N. ;
Easton, John ;
Zhu, Xiaofan ;
Zhang, Jingliao ;
Cheng, Cheng ;
Raphael, Benjamin J. ;
Tang, Jingyan ;
Downing, James R. ;
Alexandrov, Ludmil B. ;
Zhou, Bin-Bing S. ;
Pui, Ching-Hon ;
Yang, Jun J. ;
Zhang, Jinghui .
BLOOD, 2020, 135 (01) :41-55
[29]   Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALL [J].
Li, Benshang ;
Li, Hui ;
Bai, Yun ;
Kirschner-Schwabe, Renate ;
Yang, Jun J. ;
Chen, Yao ;
Lu, Gang ;
Tzoneva, Gannie ;
Ma, Xiaotu ;
Wu, Tongmin ;
Li, Wenjing ;
Lu, Haisong ;
Ding, Lixia ;
Liang, Huanhuan ;
Huang, Xiaohang ;
Yang, Minjun ;
Jin, Lei ;
Kang, Hui ;
Chen, Shuting ;
Du, Alicia ;
Shen, Shuhong ;
Ding, Jianping ;
Chen, Hongzhuan ;
Chen, Jing ;
von Stackelberg, Arend ;
Gu, Longjun ;
Zhang, Jinghui ;
Ferrando, Adolfo ;
Tang, Jingyan ;
Wang, Shengyue ;
Zhou, Bin-Bing S. .
NATURE MEDICINE, 2015, 21 (06) :563-571
[30]   A Gain of Function Mutation in the NSD2 Histone Methyltransferase Drives Glucocorticoid Resistance of Acute Lymphoblastic Leukemia [J].
Li, Jianping ;
Troche, Catalina ;
Swaroop, Alok ;
Kulis, Marta ;
Oyer, Jon ;
Will, Christine ;
Dupere-Richer, Daphne ;
Riva, Alberto ;
Pipe, Crissandra ;
Norton, Sharon ;
Bennett, Richard Lynn ;
Licht, Jonathan D. .
BLOOD, 2018, 132